Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$3,153.02 /

-71.98 (-2.23%)

09:08
05/13/21
05/13
09:08
05/13/21
09:08

Amazon hiring 75K workers, average starting pay over $17 per hour, start bonus

Amazon announced that it is hiring 75,000 people in its fulfillment and logistics network across the U.S. and Canada as it continues to expand its footprint and serve customers. Amazon recently announced pay increases across its fulfillment and transportation networks, and these open roles offer an average starting pay of over $17 per hour, plus sign-on bonuses in many locations of up to $1,000. In addition, the company offers full-time employees industry-leading benefits, which include health, vision, and dental insurance, 401(k) with 50% company match, paid parental leave, and access to various company-funded upskilling opportunities, including Amazon's innovative Career Choice program, which prepays 95% of tuition for courses in high-demand fields. "We look forward to hiring 75,000 associates across our fulfillment and transportation network," said Alicia Boler Davis, Vice President of Global Customer Fulfillment at Amazon. "Working at Amazon also comes with an unwavering commitment to safety, especially as we continue to navigate a global pandemic. In addition to the great pay and robust benefits available to new hires starting on their first day, we're offering a $100 benefit to new hires who come to Amazon already vaccinated for COVID-19."

  • 17

    May

  • 26

    May

AMZN Amazon.com
$3,153.02 /

-71.98 (-2.23%)

05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
05/12/21 SVB Leerink
GoodRx moat still intact as Amazon Pharmacy push continues, says SVB Leerink
05/12/21 Citi
Amazon.com price target raised to $4,175 from $3,750 at Citi
05/04/21 R5 Capital
Amazon.com upgraded to Buy from Hold at R5 Capital

TODAY'S FREE FLY STORIES

General news
FX Update: The dollar majors have been plying narrow ranges » 03:15
06/16/21
06/16
03:15
06/16/21
03:15
$ECON

Economic Data

/

+

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
FOMC Preview: » 02:05
06/16/21
06/16
02:05
06/16/21
02:05
$ECON

Economic Data

/

+

FOMC Preview: The big…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
Asian Market Update: » 02:00
06/16/21
06/16
02:00
06/16/21
02:00
$ECON

Economic Data

/

+

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
FOMC Forecast revisions: » 02:00
06/16/21
06/16
02:00
06/16/21
02:00
$ECON

Economic Data

/

+

FOMC Forecast revisions:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
U.S. trade price preview » 02:00
06/16/21
06/16
02:00
06/16/21
02:00
$ECON

Economic Data

/

+

U.S. trade price preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
U.S. housing starts preview » 02:00
06/16/21
06/16
02:00
06/16/21
02:00
$ECON

Economic Data

/

+

U.S. housing starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
Treasury Market Summary » 21:15
06/15/21
06/15
21:15
06/15/21
21:15
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: the advent of the FOMC left the markets on hold, though with a bearish bent as it will be a big ask for the FOMC to come out on the dovish side of the spectrum. The Fed is universally expected to maintain its ultra-accommodative posture with it 0%-0.25% rate band along with the $120 B in asset purchases. The big question, however, is whether the Fed starts to talk about QE tapering. The potential that the Committee does start discussions has given the bears a slight upper hand, especially given current conditions where longer dated rates were at better than 3-month lows with Wall Street at record highs. The 10-year finished at 1.50%, having ranged narrowly around that level. The NASDAQ dropped -0.71%, while the Dow was off -0.27%, with the S&P 500 slipping -0.2%. The mix of results from a very heavy data calendar, including retail sales, PPI, production, the Empire State index, and the NAHB, had no impact. The Treasury's $24 B 20-year reopening was well bid.

ShowHide Related Items >><<
$ECON Economic Data
/

+

Syndicate
Protagonist Therapeutics 3.05M share Spot Secondary priced at $37.75 » 21:11
06/15/21
06/15
21:11
06/15/21
21:11
PTGX

Protagonist Therapeutics

$38.18 /

-2.96 (-7.19%)

The deal size was…

The deal size was increased to $3.05M shares from 2.4M and priced below last closing price of $38.15. JPMorgan, Jefferies and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$38.18 /

-2.96 (-7.19%)

PTGX Protagonist Therapeutics
$38.18 /

-2.96 (-7.19%)

06/14/21 Northland
Protagonist Therapeutics price target raised to $47 from $42 at Northland
05/24/21 Northland
Protagonist Therapeutics initiated with an Outperform at Northland
05/12/21 Piper Sandler
Piper says Protagonist Therapeutics' EHA abstract includes 'spectacular' data
03/11/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $36 from $33 at H.C. Wainwright
PTGX Protagonist Therapeutics
$38.18 /

-2.96 (-7.19%)

  • 16
    Jun
  • 11
    Dec
Recommendations
Helios Technologies price target raised to $94 from $89 at Baird » 20:29
06/15/21
06/15
20:29
06/15/21
20:29
HLIO

Helios Technologies

$73.85 /

+1.88 (+2.61%)

Baird analyst Mircea…

Baird analyst Mircea Dobre raised the firm's price target on Helios Technologies to $94 from $89 and keeps an Outperform rating on the shares. The analyst cites the management moving forward its $1B revenue target from 2025 to 2023 and also believes that the company has developed an integrated operating model to coordinate engineering, manufacturing, and sales across brands and applications laying the groundwork for continued outsized growth.

ShowHide Related Items >><<
HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

05/11/21 Baird
Helios Technologies price target raised to $89 from $84 at Baird
05/11/21 Baird
Helios Technologies updated guidance above previous range, says Baird
03/02/21 Baird
Helios Technologies price target raised to $82 from $72 at Baird
10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

Hot Stocks
Corporacion America Airport reports May passenger traffic up 1,279% y/y » 20:12
06/15/21
06/15
20:12
06/15/21
20:12
CAAP

Corporacion America Airport

$5.28 /

+0.01 (+0.19%)

Corporacion America…

Corporacion America Airports reported a 1,279% year-over-year increase in passenger traffic in May 2021, and a 73.6% decline when compared to the same period of 2019.

ShowHide Related Items >><<
CAAP Corporacion America Airport
$5.28 /

+0.01 (+0.19%)

CAAP Corporacion America Airport
$5.28 /

+0.01 (+0.19%)

CAAP Corporacion America Airport
$5.28 /

+0.01 (+0.19%)

CAAP Corporacion America Airport
$5.28 /

+0.01 (+0.19%)

Upgrade
Beiersdorf upgraded to Buy from Hold at Jefferies » 20:10
06/15/21
06/15
20:10
06/15/21
20:10
BDRFY

Beiersdorf

$24.53 /

+0.191 (+0.78%)

Jefferies analyst Martin…

Jefferies analyst Martin Deboo upgraded Beiersdorf to Buy from Hold with a EUR 120 price target.

ShowHide Related Items >><<
BDRFY Beiersdorf
$24.53 /

+0.191 (+0.78%)

06/04/21 Citi
Beiersdorf upgraded to Buy from Sell at Citi
06/02/21 Berenberg
Beiersdorf upgraded to Buy from Hold at Berenberg
05/04/21 Berenberg
Beiersdorf price target raised to EUR 92 from EUR 90 at Berenberg
04/30/21 Barclays
Beiersdorf price target raised to EUR 113 from EUR 108 at Barclays
Syndicate
Inhibikase Therapeutics 15M share Secondary priced at $3.00 » 19:47
06/15/21
06/15
19:47
06/15/21
19:47
IKT

Inhibikase Therapeutics

$4.03 /

-0.825 (-16.99%)

The deal priced below…

The deal priced below last closing price of $4.04. ThinkEquity is acting as sole book running manager for the offering.

ShowHide Related Items >><<
IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

04/26/21 ThinkEquity
Inhibikase Therapeutics initiated with a Buy at ThinkEquity
  • 28
    Oct
IKT Inhibikase Therapeutics
$4.03 /

-0.825 (-16.99%)

Syndicate
Convey Holding 13.333M share IPO priced at $14.00 » 19:44
06/15/21
06/15
19:44
06/15/21
19:44
CNVY

Convey Holding

/

+

The deal priced at low…

The deal priced at low end of $14.00-$16.00 range. BofA, Goldman Sachs and JPMorgan are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 16
    Jun
Periodicals
GM to boost spending on electric and autonomous cars by 30%, Reuters reports » 19:43
06/15/21
06/15
19:43
06/15/21
19:43
GM

General Motors

$60.81 /

+0.02 (+0.03%)

General Motors will…

General Motors will increase its global spending on electric and autonomous cars to $35B, which is 30% higher than the company's most recent forecast, Reuters' David Shepardson reports, citing people briefed on the matter. As part of the expanded spending, GM will build two new battery plans and will shift forward some of its EV investments, the report states. Reference Link

ShowHide Related Items >><<
GM General Motors
$60.81 /

+0.02 (+0.03%)

GM General Motors
$60.81 /

+0.02 (+0.03%)

06/07/21 Barclays
General Motors price target raised to $70 from $66 at Barclays
06/04/21 JPMorgan
General Motors price target raised to $73 from $71 at JPMorgan
06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
05/18/21 Tudor Pickering
GM 'well positioned' to lean into electrification trend, says Tudor Pickering
GM General Motors
$60.81 /

+0.02 (+0.03%)

GM General Motors
$60.81 /

+0.02 (+0.03%)

GM General Motors
$60.81 /

+0.02 (+0.03%)

GM General Motors
$60.81 /

+0.02 (+0.03%)

Hot Stocks
Diginex and EQUOS rebrand to EQONEX » 19:20
06/15/21
06/15
19:20
06/15/21
19:20
EQOS

Diginex

$7.71 /

-0.6 (-7.22%)

Diginex Limited announced…

Diginex Limited announced that it is unifying its businesses under the brand, EQONEX. The rebrand brings together under the EQONEX Group brand, its cryptocurrency exchange, custody platform, multi-venue trading business, over-the-counter offering, its asset management solution, securitization business and the upcoming investment products and borrowing and lending businesses. EQUOS, the cryptocurrency exchange will be known as EQONEX and Diginex Capital, the digital asset securitization business will be rebranded to EQONEX Capital. The investment products business will be called EQONEX Investment Products and the anticipated borrowing and lending platform will become EQONEX Lending. Diginex Access, the multi-venue trading platform, will rebrand to Access Trading. Digivault, the UK Financial Conduct Authority-registered crypto-asset custodian, will continue to operate under its current name. Bletchley Park, the crypto fund of funds, will also operate under its current name. The company's corporate name will remain Diginex Limited and the company will continue to trade on the Nasdaq Stock Exchange as Diginex Limited, pending a resolution to rename the corporate entity at the company's AGM later this year. The rebrand follows the divestment of Diginex Solutions, the ESG blockchain solutions company, in May 2020 and the impending lapse of the license to use the "Diginex" brand at the end of the month.

ShowHide Related Items >><<
EQOS Diginex
$7.71 /

-0.6 (-7.22%)

EQOS Diginex
$7.71 /

-0.6 (-7.22%)

05/05/21 H.C. Wainwright
Diginex initiated with a Buy at H.C. Wainwright
EQOS Diginex
$7.71 /

-0.6 (-7.22%)

EQOS Diginex
$7.71 /

-0.6 (-7.22%)

Downgrade
Whitehaven Coal downgraded to Neutral from Buy at Citi » 19:14
06/15/21
06/15
19:14
06/15/21
19:14
WHITF

Whitehaven Coal

$1.65 /

+ (+0.00%)

Citi analyst Paul…

Citi analyst Paul McTaggart downgraded Whitehaven Coal to Neutral from Buy with a A$2.20 price target.

ShowHide Related Items >><<
WHITF Whitehaven Coal
$1.65 /

+ (+0.00%)

05/13/21 Credit Suisse
Whitehaven Coal upgraded to Outperform from Neutral at Credit Suisse
02/17/21 Goldman Sachs
Whitehaven Coal upgraded to Buy from Neutral at Goldman Sachs
07/01/20 Citi
Whitehaven Coal upgraded to Buy from Neutral at Citi
Hot Stocks
PSEG general counsel Linde sells 29,500 common shares » 18:53
06/15/21
06/15
18:53
06/15/21
18:53
PEG

PSEG

$62.35 /

+0.5 (+0.81%)

In a regulatory filing,…

In a regulatory filing, PSEG general counsel Tamara Louise Linde disclosed the sale of 29,500 common shares of the company on June 14 at a price of $61.7113 per share.

ShowHide Related Items >><<
PEG PSEG
$62.35 /

+0.5 (+0.81%)

PEG PSEG
$62.35 /

+0.5 (+0.81%)

05/25/21 Barclays
PSEG price target raised to $67 from $62 at Barclays
05/24/21 Seaport Global
PSEG upgraded to Buy from Neutral at Seaport Global
04/29/21 Mizuho
PSEG upgraded to Buy from Neutral at Mizuho
04/14/21 KeyBanc
PSEG price target raised to $65 from $60 at KeyBanc
PEG PSEG
$62.35 /

+0.5 (+0.81%)

Initiation
Primoris initiated with a Neutral at Goldman Sachs » 18:27
06/15/21
06/15
18:27
06/15/21
18:27
PRIM

Primoris

$31.47 /

-0.11 (-0.35%)

Goldman Sachs analyst…

Goldman Sachs analyst Jerry Revich initiated coverage of Primoris with a Neutral rating and $35 price target. The company has successfully derisked its legacy portfolio over the past 5 years, the analyst tells investors in a research note, adding that he is also positive on its more recent expansion into higher margin and growth solar and telecom end markets. Revich adds however that while Primoris should see steady growth in electric and telecom utility businesses, its Pipeline, Civil and Industrial/Engineering businesses representing about 40% of sales face a challenging outlook.

ShowHide Related Items >><<
PRIM Primoris
$31.47 /

-0.11 (-0.35%)

PRIM Primoris
$31.47 /

-0.11 (-0.35%)

02/24/21 DA Davidson
Primoris price target raised to $42 from $35 at DA Davidson
12/16/20 DA Davidson
Primoris price target raised to $35 from $28 at DA Davidson
10/27/20 KeyBanc
Primoris downgraded to Sector Weight on valuation at KeyBanc
10/27/20 KeyBanc
Primoris downgraded to Sector Weight from Overweight at KeyBanc
PRIM Primoris
$31.47 /

-0.11 (-0.35%)

  • 18
    Mar
Hot Stocks
Akamai CEO: Revenue from security is growing » 18:26
06/15/21
06/15
18:26
06/15/21
18:26
AKAM

Akamai

$118.11 /

+0.12 (+0.10%)

In an interview on…

In an interview on CNBC's Mad Money, Dr. Tom Leighton said security is now 37% of Akamai's revenue. The company takes a different approach to cyber security, he noted. The way enterprises defend themselves digitally is poor, Leighton argued, noting they have to adopt multi-factor authentication. The government can and should help companies set a baseline of security standards, he said.

ShowHide Related Items >><<
AKAM Akamai
$118.11 /

+0.12 (+0.10%)

AKAM Akamai
$118.11 /

+0.12 (+0.10%)

05/20/21 Piper Sandler
Akamai price target raised to $130 from $121 at Piper Sandler
05/05/21 KeyBanc
Akamai price target raised to $130 from $119 at KeyBanc
04/26/21 Piper Sandler
Akamai moving higher on activist speculation, says Piper Sandler
03/15/21 Credit Suisse
Akamai assumed with a Neutral at Credit Suisse
AKAM Akamai
$118.11 /

+0.12 (+0.10%)

AKAM Akamai
$118.11 /

+0.12 (+0.10%)

AKAM Akamai
$118.11 /

+0.12 (+0.10%)

AKAM Akamai
$118.11 /

+0.12 (+0.10%)

On The Fly
Fly Intel: After-Hours Movers » 18:24
06/15/21
06/15
18:24
06/15/21
18:24
FORD

Forward Industries

$2.73 /

-0.15 (-5.21%)

, CATB

Catabasis Pharmaceuticals

$2.04 /

-0.07 (-3.32%)

, ATRA

Atara Biotherapeutics

$14.00 /

-0.67 (-4.57%)

, DTEA

DavidsTea

$5.32 /

-0.08 (-1.48%)

, ORCL

Oracle

$81.64 /

-0.95 (-1.15%)

, LZB

La-Z-Boy

$42.35 /

-0.185 (-0.43%)

, HRB

H&R Block

$25.26 /

-0.265 (-1.04%)

, APRN

Blue Apron

$5.54 /

-0.315 (-5.38%)

, RBLX

Roblox

$89.80 /

+2.02 (+2.30%)

, NMG

Nouveau Monde

$11.06 /

-0.03 (-0.27%)

Check out this evening's…

ShowHide Related Items >><<
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

NMG Nouveau Monde
$11.06 /

-0.03 (-0.27%)

LZB La-Z-Boy
$42.35 /

-0.185 (-0.43%)

HRB H&R Block
$25.26 /

-0.265 (-1.04%)

FORD Forward Industries
$2.73 /

-0.15 (-5.21%)

CATB Catabasis Pharmaceuticals
$2.04 /

-0.07 (-3.32%)

ATRA Atara Biotherapeutics
$14.00 /

-0.67 (-4.57%)

APRN Blue Apron
$5.54 /

-0.315 (-5.38%)

FORD Forward Industries
$2.73 /

-0.15 (-5.21%)

CATB Catabasis Pharmaceuticals
$2.04 /

-0.07 (-3.32%)

05/12/21 Ladenburg
Ladenburg starts Catabasis Pharmaceuticals at Buy with $6 price target
05/12/21 Ladenburg
Catabasis Pharmaceuticals initiated with a Buy at Ladenburg
03/11/21 Oppenheimer
Catabasis Pharmaceuticals upgraded to Outperform at Oppenheimer
03/11/21 Oppenheimer
Catabasis upgraded to Outperform from Perform at Oppenheimer
ATRA Atara Biotherapeutics
$14.00 /

-0.67 (-4.57%)

05/13/21
Fly Intel: Top five analyst upgrades
05/13/21 JPMorgan
Atara Biotherapeutics upgraded to Overweight from Neutral at JPMorgan
03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
DTEA DavidsTea
$5.32 /

-0.08 (-1.48%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
05/18/21 Jefferies
Oracle price target raised to $75 from $65 at Jefferies
05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Barclays
Oracle downgraded to Equal Weight from Overweight at Barclays
LZB La-Z-Boy
$42.35 /

-0.185 (-0.43%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
HRB H&R Block
$25.26 /

-0.265 (-1.04%)

05/31/21 BMO Capital
H&R Block price target raised to $26 from $21 at BMO Capital
05/24/21 Barrington
H&R Block price target raised to $28 from $24 at Barrington
03/11/21 BMO Capital
H&R Block price target raised to $21 from $18 at BMO Capital
03/10/21 Barrington
H&R Block price target raised to $24 from $21 at Barrington
APRN Blue Apron
$5.54 /

-0.315 (-5.38%)

10/30/20 Canaccord
Blue Apron price target lowered to $14 from $18 at Canaccord
07/30/20 Canaccord
Canaccord upgrades Blue Apron as growth returns
07/30/20 Canaccord
Blue Apron upgraded to Buy from Hold at Canaccord
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

06/01/21 Truist
Roblox price target raised to $103 from $83 at Truist
05/12/21 Truist
Roblox price target raised to $83 from $78 at Truist
05/11/21 Truist
Roblox price target raised to $83 from $78 at Truist
05/11/21 Morgan Stanley
Roblox price target raised to $87 from $80 at Morgan Stanley
NMG Nouveau Monde
$11.06 /

-0.03 (-0.27%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

LZB La-Z-Boy
$42.35 /

-0.185 (-0.43%)

HRB H&R Block
$25.26 /

-0.265 (-1.04%)

DTEA DavidsTea
$5.32 /

-0.08 (-1.48%)

CATB Catabasis Pharmaceuticals
$2.04 /

-0.07 (-3.32%)

ATRA Atara Biotherapeutics
$14.00 /

-0.67 (-4.57%)

APRN Blue Apron
$5.54 /

-0.315 (-5.38%)

  • 16
    Jun
  • 16
    Jun
  • 09
    Dec
  • 06
    Aug
RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

HRB H&R Block
$25.26 /

-0.265 (-1.04%)

APRN Blue Apron
$5.54 /

-0.315 (-5.38%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

LZB La-Z-Boy
$42.35 /

-0.185 (-0.43%)

HRB H&R Block
$25.26 /

-0.265 (-1.04%)

DTEA DavidsTea
$5.32 /

-0.08 (-1.48%)

ATRA Atara Biotherapeutics
$14.00 /

-0.67 (-4.57%)

RBLX Roblox
$89.80 /

+2.02 (+2.30%)

ORCL Oracle
$81.64 /

-0.95 (-1.15%)

HRB H&R Block
$25.26 /

-0.265 (-1.04%)

DTEA DavidsTea
$5.32 /

-0.08 (-1.48%)

APRN Blue Apron
$5.54 /

-0.315 (-5.38%)

Earnings
Avita Medical raises Q4 revenue view to $9.5M-$9.7M from $8.2M-$8.6M » 18:12
06/15/21
06/15
18:12
06/15/21
18:12
RCEL

Avita Medical

$19.24 /

-0.0301 (-0.16%)

Consensus is for Q4…

Consensus is for Q4 revenue $7.74M. AVITA Medical announced preliminary, unaudited financial results for the Q4. For the Q4 AVITA Medical has to date realized total revenue in excess of its Q4 guidance range of $8.2M-$8.6M. Based on the strength of both RECELL commercial revenue and BARDA related revenue, the Company is raising fiscal Q4 guidance to $9.5M-$9.7M, consisting of $6.0M-$6.2M of RECELL commercial revenue and $3.5M of RECELL revenue associated with BARDA, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority within the Office of the Assistance Secretary for Preparedness and Response. RECELL commercial revenue as revised in the guidance reflects a 55%-60% increase over the prior year period and 30%-34% increase over the Q3. "As people begin to return to normal activities after the confines of the COVID-19 pandemic, we have seen an increase in burn accidents requiring treatment with the RECELL System in burn centers across the country," said Mike Perry, AVITA Medical's CEO.

ShowHide Related Items >><<
RCEL Avita Medical
$19.24 /

-0.0301 (-0.16%)

RCEL Avita Medical
$19.24 /

-0.0301 (-0.16%)

03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Piper Sandler
Avita Medical initiated with an Overweight at Piper Sandler
08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
  • 25
    Feb
Hot Stocks
AT&T CFO confident in achieving 67M-70M HBO Max customers by end of 2021 » 18:10
06/15/21
06/15
18:10
06/15/21
18:10
T

AT&T

$29.29 /

+0.195 (+0.67%)

AT&T CFO Pascal…

AT&T CFO Pascal Desroches said he expects WarnerMedia's second-quarter results to benefit from positive comparisons to the second quarter of 2020, which represented the worst of the pandemic impacts in that business unit. He also said that in the second half of the year, he expects WarnerMedia to benefit from improvements in advertising revenues, a return to theaters and run rate benefits from the second-half 2020 restructuring. He also expressed confidence in the upcoming planned international launch of HBO Max and in the company's ability to deliver on its guidance of 67M to 70M HBO Max customers by the end of 2021. Desroches reiterated the guidance AT&T previously provided for 2022-2024 after the expected close of the pending WarnerMedia-Discovery transaction: Low-single digit revenue CAGR and mid-single digit adjusted EBITDA and adjusted EPS CAGR. The company expects to generate $20B plus in free cash flow on an annual basis post-close, with a dividend payout ratio in the 40% to 43% range4 for a total dividend payout of $8B to $9B per year. Also during that time period, the company expects to increase capital investment to around $24B annually, focused on 5G and fiber. The company also expects net debt to adjusted EBITDA in the 2.6x range after the transaction closes, moving to less than 2.5x by year-end 2023. AT&T expects to have the optionality to repurchase shares once net debt to adjusted EBITDA is less than 2.5x. Ultimately the company's capital allocation decisions after close of the WarnerMedia transaction will be guided foremost by where management expects to generate the best returns for its shareholder base. Desroches also reiterated that the company doesn't expect to reset the current dividend until after the proposed WarnerMedia-Discovery transaction is approved and closed. After close of the transaction, he expects that the resized dividend will continue to deliver a very attractive yield in the 95th percentile of dividend yielding stocks.

ShowHide Related Items >><<
T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

05/24/21 Morgan Stanley
AT&T price target lowered to $32 from $34 at Morgan Stanley
05/24/21 Benchmark
Benchmark does not 'attach any credence' to idea AT&T could buy Charter
05/24/21 MoffettNathanson
MoffettNathanson downgrades Discovery to Neutral after WarnerMedia deal news
05/24/21 MoffettNathanson
Discovery downgraded to Neutral from Buy at MoffettNathanson
T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

Hot Stocks
AT&T sees C-band spectrum covering 200M people by end of 2023 » 18:08
06/15/21
06/15
18:08
06/15/21
18:08
T

AT&T

$29.29 /

+0.195 (+0.67%)

AT&T CFO Pascal…

AT&T CFO Pascal Desroches provided an update to shareholders at the Credit Suisse Communications conference. Desroches said that AT&T's network is performing as well as it ever has and that as the company accelerates its deployment of C-band spectrum, it expects to cover 200M people by the end of 2023. Desroches indicated that the company's outlook includes expectations for continued elevated wireless competition and thus recent promotional activity by other wireless providers does not come as a material surprise. Desroches also said the company's plan to double the size of AT&Ts fiber footprint to about 30M customer locations by year-end 2025 should open up new use cases and opportunities given the company's integrated fiber deployment strategy and penetration trends in areas where fiber has already been deployed.

ShowHide Related Items >><<
T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

05/24/21 Morgan Stanley
AT&T price target lowered to $32 from $34 at Morgan Stanley
05/24/21 Benchmark
Benchmark does not 'attach any credence' to idea AT&T could buy Charter
05/24/21 MoffettNathanson
MoffettNathanson downgrades Discovery to Neutral after WarnerMedia deal news
05/24/21 MoffettNathanson
Discovery downgraded to Neutral from Buy at MoffettNathanson
T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

T AT&T
$29.29 /

+0.195 (+0.67%)

Hot Stocks
Crispr gets FDA orphan drug designation in T-Cell Lymphoma treatment » 18:04
06/15/21
06/15
18:04
06/15/21
18:04
CRSP

Crispr Therapeutics

$123.67 /

-5.14 (-3.99%)

The FDA granted Crispr…

The FDA granted Crispr Therapeutics orphan drug designation for its Cas9-mediated genetically modified CAR T cells targeting CD70 antigen in the treatment of T-cell Lymphoma. Reference Link

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$123.67 /

-5.14 (-3.99%)

CRSP Crispr Therapeutics
$123.67 /

-5.14 (-3.99%)

06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Citi
Crispr Therapeutics upgraded to Neutral from Sell at Citi
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
CRSP Crispr Therapeutics
$123.67 /

-5.14 (-3.99%)

  • 01
    Jul
CRSP Crispr Therapeutics
$123.67 /

-5.14 (-3.99%)

CRSP Crispr Therapeutics
$123.67 /

-5.14 (-3.99%)

Periodicals
Biden weighs small cut to biofuel targets to appease refiners, Bloomberg says » 18:03
06/15/21
06/15
18:03
06/15/21
18:03
DK

Delek US

$22.60 /

+0.19 (+0.85%)

, TSO

Tesoro

/

+

, VLO

Valero

$82.30 /

+0.36 (+0.44%)

, PSX

Phillips 66

$92.11 /

+0.67 (+0.73%)

, WNR

Western Refining

$36.18 /

+ (+0.00%)

, MPC

Marathon Petroleum

$63.66 /

+0.66 (+1.05%)

, HFC

HollyFrontier

$34.96 /

+1.155 (+3.42%)

The Biden administration…

The Biden administration is considering small cut to biofuel targets that may be flat or "lower" as the administration tries to appease to "blue-collar refining workers and advance a clean-energy agenda, wrote Jennifer A Dlouhy and Kim Chipman of Bloomberg Green. "The Environmental Protection Agency is set to propose renewable fuel requirements within weeks, according to several people familiar with the strategy," noted the Bloomberg story. Publicly traded companies in the space include Delek US (DK), HollyFrontier (HFC), Marathon Petroleum (MPC), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO) and Western Refining (WNR). Reference Link

ShowHide Related Items >><<
VLO Valero
$82.30 /

+0.36 (+0.44%)

PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

MPC Marathon Petroleum
$63.66 /

+0.66 (+1.05%)

HFC HollyFrontier
$34.96 /

+1.155 (+3.42%)

DK Delek US
$22.60 /

+0.19 (+0.85%)

DK Delek US
$22.60 /

+0.19 (+0.85%)

06/09/21 Citi
Delek US price target raised to $25 from $24 at Citi
05/28/21 Tudor Pickering
Delek US upgraded to Buy from Hold at Tudor Pickering
05/25/21 Piper Sandler
Delek US upgraded to Overweight from Neutral at Piper Sandler
04/01/21 Piper Sandler
Delek US price target raised to $23 from $20 at Piper Sandler
TSO Tesoro
/

+

VLO Valero
$82.30 /

+0.36 (+0.44%)

06/09/21 Citi
Valero price target lowered to $119 from $121 at Citi
05/17/21 Mizuho
Valero price target raised to $94 from $86 at Mizuho
05/03/21 Citi
Citi adds Valero to US Focus List, boosts target to $121
04/27/21 RBC Capital
Valero price target raised to $94 from $82 at RBC Capital
PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

06/09/21 Citi
Citi boosts Phillips 66 target to $126, opens 'positive catalyst watch'
05/17/21 Mizuho
Phillips 66 price target raised to $100 from $96 at Mizuho
05/12/21 Credit Suisse
Phillips 66 price target raised to $95 from $90 at Credit Suisse
05/04/21 RBC Capital
Phillips 66 price target raised to $37 from $33 at RBC Capital
WNR Western Refining
$36.18 /

+ (+0.00%)

MPC Marathon Petroleum
$63.66 /

+0.66 (+1.05%)

06/09/21 Citi
Marathon Petroleum price target raised to $70 from $58 at Citi
05/17/21 Credit Suisse
Marathon Petroleum reinstated with an Outperform at Credit Suisse
05/14/21 Wells Fargo
Marathon Petroleum's sale of Speedway closes, says Wells Fargo
05/05/21 RBC Capital
Marathon Petroleum price target raised to $70 from $60 at RBC Capital
HFC HollyFrontier
$34.96 /

+1.155 (+3.42%)

05/28/21 Tudor Pickering
HollyFrontier downgraded to Hold from Buy at Tudor Pickering
05/20/21 Goldman Sachs
HollyFrontier downgraded to Sell from Neutral at Goldman Sachs
04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
VLO Valero
$82.30 /

+0.36 (+0.44%)

PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

MPC Marathon Petroleum
$63.66 /

+0.66 (+1.05%)

HFC HollyFrontier
$34.96 /

+1.155 (+3.42%)

DK Delek US
$22.60 /

+0.19 (+0.85%)

VLO Valero
$82.30 /

+0.36 (+0.44%)

TSO Tesoro
/

+

PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

DK Delek US
$22.60 /

+0.19 (+0.85%)

VLO Valero
$82.30 /

+0.36 (+0.44%)

PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

MPC Marathon Petroleum
$63.66 /

+0.66 (+1.05%)

HFC HollyFrontier
$34.96 /

+1.155 (+3.42%)

PSX Phillips 66
$92.11 /

+0.67 (+0.73%)

MPC Marathon Petroleum
$63.66 /

+0.66 (+1.05%)

HFC HollyFrontier
$34.96 /

+1.155 (+3.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.